SELLAS Life Sciences Group Inc (SLS) Quote

VERY OBSERVANT, THANK YOU FOR THE ANALOGY! TOMORROW MIGHT MAKE A DIFFERENCE****WE SHALL SEE

Lol, oh there are still a stash of those, in the 20’s! $$$$$!!

You should have taken CVNA which go to da moon
Now back to getting richer

Huge move up could happen anytime, lottery play could go to da moon! $$$$$

With positive REGAL results this will eventually explode

According to the charters, which I am not, 9 million volume traded so far today - largest volume day in 3 years - 6 of the 9 million sold short

SLS under $2

SURPRISED SLS IS NOT MOVING**** WAS AN EXCELLENT NEWS***** HOW ARE U *******

YOU ARE NOT AS FREQUENT AS BEFORE , YOU MUST BE SOMEWHERE ELSE***SHARE THE KNOWLEDGE

Let er rip

1.27 SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level $SLS https://t.co/bQBsEQo7jc— Health Stocks News (@health_stocks) May 1, 2024

Somebody shorted the sh.. out of this today, pretty risky at this point, but whatever….

Yahoo finance add sls and review of the conversations tab.

you have a link ?

On yahoo they are talking 4 min.

Agree, might see 1.70’s again, worth the risk with a stop limit on shares purchased at 1$ or more

ok thanks

I believe it’s gonna before EOM… pr stated idmc scheduled ‘by’ EOM…

yup think next month data phase3 end april ... should see 1.50s before data

Maybe another pop to 1.60

SLS 10Q due 3/22

SLS under $2

Hit an run with this one

No way, lotto play here. This is nothing but risk

Let’s go $$$$$ reeling $$$$$$

Junk

SLS new 52 week low

And Dilution.

Merry Christmas $$$$$

Doubt it, insiders just sold shares!

Rumor mill over on Stocktwits is that STELLAS is about to receive Orphan Drug status for their T-cell lymphoma treatment. No PR out yet but,.... Dated today,...

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=977523

Climbing back up

SLS new 52 week low

Sex always makes money! Lol

SLS FDA NEWS WOOHOOOOOO WOOHOOOOOO

SLS under $2

After that dilution it’l double in price, always does

Breakout coming, this science could be a game changer

Fingers crossed! Still an unknown, to us, but after the first IDMC & positive sentiment from Tuesday’s KOL TC it’s hard to imagine GPS not achieving its P3 primary endpoints!

News coming? It’s rippn

3.09 trade! Lmao, mm’s will do anything to get cheapies. This ticker could be a huge play moving forwsrd $$$

Going to 4

Added to the stash

“Following a prespecified review of unblinded data by the IDMC in accordance with its charter, its recommendation to continue the REGAL study as is, and with trial conduct and integrity intact, is outstanding news.” This quote was from the Sellas PR… does any know when the next ‘schedule’ IDMC review is? Or is that info not available to the public?

Back in today for the ride

Wow glad we sold, held a few free ones, big hit today on the PR

Any thoughts here moving forward, still up over 100% from those lows a few weeks ago.

Sls looking good from 2$ range! $$$$

The update call on its Phase 3 REGAL clinical trial of galinpepimut-S (GPS) in patients with acute myeloid leukemia (AML) is on November 14, 2022.


The call will be facilitated by SELLAS management, including SELLAS' President and CEO, Angelos Stergiou, MD, ScD h.c., and Senior Vice President, Clinical Development, Dragan Cicic, MD, who will be joined by leading cancer researcher, M. Yair Levy, M.D., Director of Hematologic Malignancies Research at the Baylor University Medical Center, and member of the REGAL Steering Committee. Further details regarding how to access the update call will be provided in the coming weeks.

Phase 3 update call news. A flop?? Who knows

Time to get in again